Anika Therapeutics Inc. (ANIK): Price and Financial Metrics


Anika Therapeutics Inc. (ANIK): $43.38

-1.38 (-3.08%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add ANIK to Watchlist
Sign Up

Industry: Biotech


Ranked

of 487

in industry

ANIK POWR Grades


  • Value is the dimension where ANIK ranks best; there it ranks ahead of 73.31% of US stocks.
  • The strongest trend for ANIK is in Stability, which has been heading up over the past 31 weeks.
  • ANIK ranks lowest in Momentum; there it ranks in the 15th percentile.

ANIK Stock Summary

  • Price to trailing twelve month operating cash flow for ANIK is currently 68.98, higher than 93.79% of US stocks with positive operating cash flow.
  • With a year-over-year growth in debt of -71.23%, Anika Therapeutics Inc's debt growth rate surpasses just 4.52% of about US stocks.
  • Over the past twelve months, ANIK has reported earnings growth of -324.47%, putting it ahead of merely 6.29% of US stocks in our set.
  • Stocks with similar financial metrics, market capitalization, and price volatility to Anika Therapeutics Inc are RDCM, WHG, PMD, RNGR, and KIQ.
  • ANIK's SEC filings can be seen here. And to visit Anika Therapeutics Inc's official web site, go to www.anikatherapeutics.com.

ANIK Price Target

For more insight on analysts targets of ANIK, see our ANIK price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $48.00 Average Broker Recommendation 1 (Strong Buy)

ANIK Stock Price Chart Interactive Chart >

Price chart for ANIK

ANIK Price/Volume Stats

Current price $43.38 52-week high $48.37
Prev. close $44.76 52-week low $31.55
Day low $43.29 Volume 100,700
Day high $45.23 Avg. volume 129,669
50-day MA $42.50 Dividend yield N/A
200-day MA $38.85 Market Cap 624.28M

Anika Therapeutics Inc. (ANIK) Company Bio


Anika Therapeutics develops, manufactures, and commercializes therapeutic products for tissue protection, healing, and repair. The company was founded in 1983 and is based in Bedford, Massachusetts.

ANIK Price Forecast Based on DCF Valuation

Current PriceDCF Fair Value Target: Forecasted Gain:
$43.38$1.04 -98%

Below please find a table outlining a discounted cash flow forecast for ANIK, in which we model out valuation assuming a variety of terminal growth rates. To summarize, we found that Anika Therapeutics Inc ranked in the 5th percentile in terms of potential gain offered. Our DCF analysis suggests the stock is overvalued by about 98%. As for the metrics that stood out in our discounted cash flow analysis of Anika Therapeutics Inc, consider:

  • In the past 5.76 years, Anika Therapeutics Inc has a compound free cash flow growth rate of -0.21%; that's higher than only 7.81% of free cash flow generating stocks in the Healthcare sector.
  • Anika Therapeutics Inc's interest coverage rate -- a measure of gross earnings relative to interest payments -- comes in at -114.17. This coverage rate is greater than that of only 1.44% of stocks we're observing for the purpose of forecasting via discounted cash flows.


Terminal Growth Rate in Free Cash FlowReturn Relative to Current Share Price
0%-98%
1%-98%
2%-98%
3%-98%
4%-98%
5%-98%

Want more companies with a valuation profile/forecast similar to that of Anika Therapeutics Inc? See ALC, MYOV, VERU, ATRS, and LNTH.


ANIK Latest News Stream


Event/Time News Detail
Loading, please wait...

ANIK Latest Social Stream


Loading social stream, please wait...

View Full ANIK Social Stream

Latest ANIK News From Around the Web

Below are the latest news stories about Anika Therapeutics Inc that investors may wish to consider to help them evaluate ANIK as an investment opportunity.

Introducing Anika Therapeutics (NASDAQ:ANIK), A Stock That Climbed 26% In The Last Year

On average, over time, stock markets tend to rise higher. This makes investing attractive. But if you choose that path...

Yahoo | June 4, 2021

Anika Hosts 2021 Virtual Investor Day

Company details multi-year Joint Preservation strategy for accelerated revenue growth and profitability Updates 2021 directional outlook and 2024 multi-year targets BEDFORD, Mass., June 03, 2021 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today will host its 2021 Virtual Investor Day beginning at 9:00am EDT. Cheryl R. Blanchard, Ph.D., President and Chief Executive Officer, and Mike Levitz, Executive Vice Pre

Yahoo | June 3, 2021

Anika Therapeutics (ANIK) Presents At UBS Global Healthcare Virtual Conference - Slideshow

The following slide deck was published by Anika Therapeutics, Inc. in conjunction with this event....

SA Transcripts on Seeking Alpha | May 28, 2021

Anika Therapeutics (ANIK) Presents At Canaccord Genuity Musculoskeletal Conference - Slideshow

The following slide deck was published by Anika Therapeutics, Inc. in conjunction with this event....

SA Transcripts on Seeking Alpha | May 24, 2021

Anika to Participate in Upcoming Virtual Investor Conferences

BEDFORD, Mass., May 04, 2021 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today announced that Dr. Cheryl Blanchard, President and Chief Executive Officer and Michael Levitz, Executive Vice President, Chief Financial Officer and Treasurer, will be participating at the following three virtual investor conferences in May: The 16th Annual Canaccord Genuity Musculoskeletal Conference on Thursday, May 20, 2021 will host a live presentation starting at 9:00 a.m. ET.The UBS Global Healthcare Virtual Conference on Tuesday, May 25, 2021 will host a live presentation starting at 8:00 a.m. ET.Oppenheimer’s MedTech, Tools & Diagnostics Summit will post a pre-recorded presentation on Wednesday, May 26, 2021. Webca...

Yahoo | May 4, 2021

Read More 'ANIK' Stories Here

ANIK Price Returns

1-mo -0.69%
3-mo 19.57%
6-mo 5.93%
1-year 30.94%
3-year -3.71%
5-year -12.87%
YTD -4.15%
2020 -12.71%
2019 54.27%
2018 -37.66%
2017 10.11%
2016 28.30%

Continue Researching ANIK

Here are a few links from around the web to help you further your research on Anika Therapeutics Inc's stock as an investment opportunity:

Anika Therapeutics Inc (ANIK) Stock Price | Nasdaq
Anika Therapeutics Inc (ANIK) Stock Quote, History and News - Yahoo Finance
Anika Therapeutics Inc (ANIK) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.8794 seconds.